Related Experiment Video
Updated: Mar 23, 2026
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Methods for PTEN in Stem Cells and Cancer Stem Cells
Suzanne Schubbert1, Jing Jiao1, Marcus Ruscetti1
1Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, CA, USA.
Abstract:
PTEN (phosphatase and tensin homologue) is the first tumor suppressor identified to have phosphatase activity and its gene is the second most frequently deleted or mutated tumor-suppressor gene associated with human cancers. Germline PTEN mutations are the cause of three inherited autosomal dominant disorders. Phosphatidylinositol 3,4,5,-triphosphate (PIP3), the product of the PI3 kinase, is one of the key intracellular targets of PTEN's phosphatase activity, although PTEN's phosphatase-independent activities have also been identified. PTEN is critical for stem cell maintenance, which contributes to its controlled tumorigenesis. PTEN loss leads the development of cancer stem cells (CSCs) that share properties with somatic stem cells, including the capacity for self-renewal and multi-lineage differentiation. Methods to isolate and functionally test stem cells and CSCs are important for understanding PTEN functions and the development of therapeutic approaches to target CSCs without having adverse effects on normal stem cells. Here, we describe protocols for the isolation and functional analysis of PTEN deficient embryonic stem cells, hematopoietic stem cells and leukemia-initiating cells (LICs), neural stem cells, and prostate stem cells and CSCs.
Insights
The tumor suppressor PTEN (phosphatase and tensin homologue) is crucial for regulating cell growth. Loss of PTEN function promotes cancer stem cells, necessitating methods to study these cells for targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Stem Cell Biology
Background:
- PTEN (phosphatase and tensin homologue) is a key tumor suppressor gene frequently altered in human cancers.
- PTEN loss is linked to inherited disorders and promotes cancer stem cell (CSC) development.
- PTEN regulates cellular processes via its phosphatase activity and other mechanisms, impacting stem cell maintenance.
Purpose of the Study:
- To describe protocols for isolating and functionally analyzing PTEN-deficient stem cells and CSCs.
- To facilitate understanding of PTEN's role in stem cell biology and tumorigenesis.
- To aid in developing targeted therapies for cancers driven by PTEN loss.
Main Methods:
- Isolation of PTEN-deficient embryonic stem cells, hematopoietic stem cells, leukemia-initiating cells (LICs), neural stem cells, and prostate stem cells/CSCs.
- Functional analysis of isolated stem cells and CSCs to assess PTEN's role.
- Utilizing established and novel techniques for stem cell and CSC characterization.
Main Results:
- Protocols for the isolation and functional analysis of various PTEN-deficient stem and CSC populations are detailed.
- The study provides a framework for investigating PTEN's multifaceted roles in different stem cell types.
- The described methods enable the study of CSCs with implications for cancer therapy.
Conclusions:
- Effective methods for studying PTEN-deficient stem cells and CSCs are essential for advancing cancer research.
- Understanding PTEN's function in stem cells is critical for developing therapies targeting CSCs.
- These protocols will support research into PTEN-related cancers and stem cell biology.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:17Stem Cell Culture